Affymax, Inc. (AFFY) Message Board
-
have you looked at OPXA? anther to consider, have deal with Merck
-
really low price, what else in pipeline
-
thanks
-
another example is ELN they never got back to there ultimate high of $61, but did recover some.
Sentiment: Hold
- Reply to
Buyout Within 60 Days_Celsion (CLSN) To Meet With Roche On Monday In NYC Predicts Sierra World equity Review.
by ladysmith5sai •Mar 8, 2013 3:27 AMPossible buyout and they can advance on technology, given small MC, but for what price?
Sentiment: Strong Buy
-
DNDN was $58 and has been stuck under $10 and at one time $3.69?
doesn't mean anything in the world of biotechs. This could stay at $3-3.50 range for quite some time. Don't think it'll spring back to $25 soon.
CLSN dropped from $9 to $1, might get a small pop soon but unless news comes out it'll stay under $2 and that goes for many bio-tech stocks out there.Sentiment: Hold
-
call next week, expect a nice pop
-
Don't forget CLSN, still in the game.
Sentiment: Strong Buy
-
CLSN will pop before earnings next thursday. should hit $1.50
Sentiment: Strong Buy
-
thanks, sounds like a better plan.
Sentiment: Buy
-
10 bagger if you are smart load up!
Sentiment: Strong Buy
-
I guess smart minds think alike , hmm
-
I am but would like Longs input, always helps. Too much trash out there if you know what I mean ;)
get lost punk!Sentiment: Buy
-
this part is important:
Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback.Sentiment: Buy
-
This was a stock we profiled last month in our article, "Speculative Boiptech Stocks That Could Bounce", and in that article, we noted the oversold chart and the expected move back to $1.60. A week later, the stock popped to an intra-day high of $1.54 for a 30% gain. Since then, there has been a slow bleed, thanks to news of financing competed at $1.24 per share. Now that financing has been completed, the company has approximately $35m in cash. Celsion has been consolidating over the last two weeks since that news at the $1 level, and could be setting up for another bounceback. Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback. Also, with the financing completed at $1.24 and the stock hovering at $1, there is good reason to expect a bounce back to that price level near term. With a market cap of $50m and some small hope for positive news in their other trials there is reason to put some speculative money in this play. A bounce back to the February $1.54 highs would mark a 50% return from here.
Sentiment: Buy
-
You are a smart investor, buyout not happening with what is going on. This will drift sideways for some time and possibly have some pops here and there. Who ever bought/shorted/covered did there thing for what ever reasons. Retailers are always the last to know.
Anything can happen but looking at it realistically I would be cautious.Sentiment: Hold
- Reply to
What time on Monday are they to report "earnings"? Before or AFTER the bell?
by benjamins72 •Mar 8, 2013 3:05 PMEarnings Call should give some clarity to future of CLSN, expect a small pop going into earnings.
Sentiment: Buy
- Reply to
Question to Longs: What if this drug gets pulled off market
by bio_maniac_00 •Mar 8, 2013 6:27 PMwhat "if"
I don't know, this is really risky investment.Sentiment: Hold
- Reply to
pfizer buy-out. Wil be announced this weekend. Congradulions longs
by averagephysique •Mar 8, 2013 5:46 PMYou are stating that AFFY met with Pfizer? Can you support this claim?
Sentiment: Hold
-
hold your shares.
Sentiment: Buy